Survival rates for patients at high risk of relapse of childhood leukemia improve with high doses of chemotherapy drug

Posted by on April 25, 2016 8:17 pm
Categories: health

Up to 20 percent of patients with high risk of relapse of acute lymphoblastic leukemia (ALL) are not cured. That could change with the results from a clinical trial that shows giving high doses of a commonly-used chemotherapy drug increases survival rates.

Leave a Reply

Your email address will not be published. Required fields are marked *